pregnant women, those who are severely allergic to vaccines, those whose heart rate and blood pressure are not stable, and other specific categories of people, are excluded from receiving the UAE COVID-19 vaccine.
As a new disease, communities possess little natural immunity to COVID-19 and vaccines are considered critical to preventing and reducing the incidence of severe illness. This study, inspired by Protection Motivation Theory (PMT), examines the relationship between citizens’ threat appraisal, coping a...
a policy allowing minors to receive the vaccine without parental consent would use a sliding scale of decision-making authority, granting greater autonomy to minors as they age while also considering the risks and benefits of vaccination. On such a calculus, COVID-19 vaccines offer high benefit...
Remarkably, these results could be helpful to plan and build trust in the vaccine, ensuring not only the enhancement of individuals’ engagement in future vaccines but also guaranteeing high levels of quality of life. In this vein, efforts should be mainly targeted towards specific personality ...
(%)*Would not accept a COVID-19 Vaccine if it is recommended to them; Total N = 8,202; n (%)⁎⁎Religion n (%)⁎⁎⁎Fear of potential side effects n (%)⁎⁎⁎Lack of trust for those creating and distributing the vaccine n (%)⁎⁎⁎Do not believe vaccines ...
COVID-19 vaccination was associated with a small increase in MCL for cycles in which participants received the first dose (0.50 days, 95% CI: 0.22, 0.78) and cycles in which participants received the second dose (0.39 days, 95% CI: 0.11, 0.67) of mRNA vaccines compared with pre-...
Vaccines (Basel) 2021;9(4). Liu Y, Han J, Li X, Chen D, Zhao X, Qiu Y, Zhang L, Xiao J, Li B, Zhao H. COVID-19 vaccination in people living with HIV (PLWH) in China: A Cross Sectional Study of Vaccine Hesitancy, Safety, and immunogenicity. Vaccines (Basel) 2021;9(12)....
There is need for effective and affordable vaccines against SARS-CoV-2 to tackle the ongoing pandemic. In this study, we describe a protein nanoparticle vaccine against SARS-CoV-2. The vaccine is based on the display of coronavirus spike glycoprotein receptor-binding domain (RBD) on a synthetic...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19) which has rapidly spread worldwide. Several human randomized clinical trials assessing potential vaccines are currently underway. There is an urgent n
It is suggested that the clearance of a viral reservoir, may be improved due to the adaptive immunity formed by additional dosage of vaccines. The notable number of the SARS-CoV-2 protein spike in patients with post-COVID-19 condition and the positive relationship between the number of ...